Eagle's Eye View: Your Weekly CV Update From ACC.org

Latest Episodes:

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Jan. 24) Jan 26, 2022

Show notes

This week’s View examines biomarkers early in pregnancy and their ability to predict hypertension risk and other disorders; clinical outcomes and pre-hospital delay among patients presenting with non–ST-segment elevation myocardial infarction (NSTEMI); and important ‘key points to remember’ from a state-of-the-art review on the diagnosis and evaluation of hypertrophic cardiomyopathy (HCM).

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Jan. 17) Jan 19, 2022

Show notes

This week’s View highlights the use of ICD therapy in ischemic vs. non-ischemic cardiomyopathy; what are the (FDG)-positron emission tomography (PET) and MRI findings, and abnormalities in patients with COVID-19; and a meta-analysis examining oral anticoagulation in AFib.

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Jan. 10) Jan 12, 2022

Show notes

This week’s View discusses the one-year outcomes of blinded physiological assessment of residual ischemia after successful PCI (DEFINE PCI); delineating whether coronary artery spasm is epicardial, microvascular, or both; and the comparison of different strategies for identifying cardiac testing in patients with chest pain.

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Dec. 22) Dec 22, 2021

Show notes

This week’s View looks at differences in results of the REDUCE-IT (Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial) and STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) trials and if they can be explained by the active and comparator oils on lipid traits and C-reactive protein (CRP). Dr. Eagle also examines whether traditional CV risk factors are associated with incident ASCVD among those with absent coronary calcium. And finally, Dr. Eagle looks at driving restrictions in those receiving a secondary prevention ICD.

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Dec. 13) Dec 15, 2021

Show notes

This week’s View examines the clinical course and short-term outcomes of suspected myocarditis following COVID-19 vaccination in patients

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Dec. 6) Dec 09, 2021

Show notes

This week’s View examines whether high-grade premature ventricular contractions (PVCs) during stress testing predict mortality in asymptomatic individuals; trends in transcatheter mitral valve therapies in the United States; and key perspectives on the newly released ACC/AHA/SCAI Coronary Revascularization Guideline.

Subscribe to Eagle’s Eye View

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Nov. 29, Part 2) Dec 01, 2021

Show notes

This episode of Eagle’s Eye View examines the long-term outcomes for patients with left main CAD treated with PCI with drug-eluting stents vs. CABG; a state-of-the-art review on acute aortic syndrome; and the impact of heart disease subtypes on in-hospital mortality of patients with COVID-19.

Subscribe to Eagle’s Eye View

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Nov. 29, Part 1) Dec 01, 2021

Show notes

This episode of Eagle’s Eye View examines direct links between distinct components of physical activity, their changes over time, and cardiorespiratory fitness rate; the rate of recurrent venous thromboembolism in patients with subsegmental pulmonary embolism managed without anticoagulation; and the effects of spinal vs. general anesthesia on the ability to walk in older adults undergoing hip surgery.

Subscribe to Eagle’s Eye View

Eagle’s Eye View: Day 3 Highlights | AHA 2021 Nov 15, 2021

Show notes

Drs. Deepak Bhatt, Payal Kohli, and Kim Eagle discuss highlights from the hottest clinical trials presented during Day 3 of the 2021 AHA Annual Scientific Session, including the PREPARE-IT 2 (0:32), AXIOMATIC-TKR (3:49), ASCEND (6:34), and REVERSE-IT (9:46) trials.

Subscribe to Eagle’s Eye View

Eagle’s Eye View: Day 2 Highlights | AHA 2021 Nov 14, 2021

Show notes

Drs. Deepak Bhatt, Payal Kohli, and Kim Eagle discuss highlights from the hottest clinical trials presented during Day 2 of the 2021 AHA Annual Scientific Session, including trials EMPULSE (0:28), EMPEROR-Preserved (2:21), CHIEF-HF (4:05), and PALACS (7:43).

Subscribe to Eagle’s Eye View

Our TOPPODCAST Picks

Follow Us

Stay Connected

Eagle’s Eye View: Your Weekly CV Update From ACC.org

Related Podcasts

Links

Stay Connected